Literature DB >> 9551911

T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death.

L Zheng1, C L Trageser, D M Willerford, M J Lenardo.   

Abstract

TCR stimulation of T lymphocytes that are activated and cycling in the presence of IL-2 leads to programmed cell death. We now show that this effect is at least partly attributable to the ability of IL-2 to dramatically increase the expression of mRNAs encoding ligands and receptors that mediate apoptosis. We also found that cyclosporin was not able to fully inhibit the TCR induction of death molecule mRNAs or TCR-induced apoptosis, although it could completely turn off IL-2 expression. The effect growth cytokines was further explored in T cells derived from mice bearing a homozygous deficiency of the IL-2R alpha-chain. We found that IL-2Ralpha-/- cells were resistant to death if IL-2 was used to induce apoptosis susceptibility, but that large amounts of other T cell growth cytokines, such as IL-4 and IL-7, could induce cell cycle progression and promote TCR-induced apoptosis. However, our findings suggest that autoimmunity and lymphoproliferation in IL-2Ralpha-/- mice can result from the loss of IL-2 stimulated feedback apoptosis and that other growth cytokines are not produced at levels sufficient to compensate for this deficit.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551911

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

Review 1.  The role of CD4 in regulating homeostasis of T helper cells.

Authors:  Rolf König; Xiaoli Shen; Rosario Maroto; Timothy L Denning
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy.

Authors:  Christopher A Klebanoff; Hung T Khong; Paul A Antony; Douglas C Palmer; Nicholas P Restifo
Journal:  Trends Immunol       Date:  2005-02       Impact factor: 16.687

Review 3.  T Cells and Regulated Cell Death: Kill or Be Killed.

Authors:  Johan Spetz; Adam G Presser; Kristopher A Sarosiek
Journal:  Int Rev Cell Mol Biol       Date:  2018-08-29       Impact factor: 6.813

Review 4.  Rational development of radiopharmaceuticals for HIV-1.

Authors:  Chuen-Yen Lau; Frank Maldarelli; William C Eckelman; Ronald D Neumann
Journal:  Nucl Med Biol       Date:  2014-01-17       Impact factor: 2.408

5.  CD4+CD28- costimulation-independent T cells in multiple sclerosis.

Authors:  S Markovic-Plese; I Cortese; K P Wandinger; H F McFarland; R Martin
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

6.  Recombinant interleukin-7 induces proliferation of naive macaque CD4+ and CD8+ T cells in vivo.

Authors:  Marcin Moniuszko; Terry Fry; Wen-Po Tsai; Michel Morre; Brigitte Assouline; Pierre Cortez; Mark G Lewis; Scott Cairns; Crystal Mackall; Genoveffa Franchini
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 7.  Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2020-08-24       Impact factor: 3.199

8.  CD4+ T cells in HIV infection show increased levels of expression of a receptor for vasoactive intestinal peptide, VPAC2.

Authors:  Hayley Ipp; Bongani B Nkambule; Timothy D Reid; Dalene de Swardt; Linda-Gail Bekker; Richard H Glashoff
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

9.  Cleavage of anti-apoptotic Bcl-2 family members after TCR stimulation contributes to the decision between T cell activation and apoptosis.

Authors:  Alan D Guerrero; Robert L Welschhans; Min Chen; Jin Wang
Journal:  J Immunol       Date:  2012-11-30       Impact factor: 5.422

Review 10.  Differential regional immune response in Chagas disease.

Authors:  Juliana de Meis; Alexandre Morrot; Désio Aurélio Farias-de-Oliveira; Déa Maria Serra Villa-Verde; Wilson Savino
Journal:  PLoS Negl Trop Dis       Date:  2009-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.